Endoscopic Medial Reepithelization for Inflammatory Canal Stenosis.
Endoscopic Medial Reepithelization for Inflammatory Canal Stenosis.
复制标题
DOI:
10.1097/mao.0000000000003625
复制
发表时间:
2022-09-01
影响因子:
2.1
通讯作者:
Tward, Aaron D.
中科院分区:
文献类型:
--
作者:
Scaria, Sonia M.;Tward, Aaron D.
Inflammatory External Auditory Canal (EAC) Stenosis arises from infiltration of inflammatory cells, edema and eventual sclerosing of the medial EAC, leading to complete obstruction and conductive hearing loss. Current treatment includes surgical resection of the affected area with widening and reepithelization of the EAC via post-auricular incision, but the condition is reported to recur with high frequency. Our aim was to assess the feasibility of endoscopic transcanal treatment as an alternative to post-auricular canalplasty and understand its effect on recurrence rates. Retrospective case review Tertiary referral center 4 patients were included who had bilateral conductive hearing loss and inflammatory canal stenosis, all with gross thickening of the tympanic membrane. Patients underwent endoscopic removal of obstructive tissue and reepithelization with split-thickness skin grafting. Post-operative air-bone gap (ABG), lack of recurrence, subjective reporting of hearing improvement, and lack of drainage. 8 out of 8 ears (n = 4 patients) had significant improvement in hearing. No recurrence has been observed in any of the patients over a mean follow-up time of 90 months (range =42–189). Average reduction in ABG was 13.40 dB (SD = 9.0) with a statistically significant difference between the pure tone average pre-operative and post-operative ABG (p =.0008; n=7). Endoscopic treatment of Inflammatory EAC Stenosis obviates the need for post-auricular incision and results in clinical improvement with a favorable recurrence rate.